Independent initiatives focused on making a difference
#AlwaysInnovating: The pharmaceutical innovation journey
Pharmaceutical innovation – the core of our industry’s work – relies on pushing the limits of scientific knowledge to advance new medicines and vaccines for the benefit of people everywhere.
#NewAntibioticsNow is a campaign that shows the slow and insidious manner in which drug resistant bacteria are undermining routine medical procedures, taking over treatments, disrupting cancer care, threatening maternal and neonatal care and slowing down medical recoveries. It calls for solutions that help sustain the development of new antibiotics, now.
Global Health Progress
Explore how the innovative pharmaceutical industry is collaborating with global health actors to achieve the Sustainable Development Goals (SDGs).
The COVID-19 Innovation Timeline
Discover the innovative pharmaceutical industry’s response to the COVID-19 pandemic to inform how we can better prepare for the next public health crisis.
#TeamVaccines spotlights the positive impact of vaccines on the world, explains the benefits of vaccines at every age and stage of life, and champions their future potential to save even more lives.
50 Years of Progress
Engage with the personal stories of individuals whose lives have been transformed over 50 years of building a better world through health innovations, overcoming challenges, making scientific advances, and partnering for progress.
The #TogetherAgainstFlu campaign continuously raises awareness of the importance of flu vaccinations for healthcare workers, older adults, and patients living with chronic conditions.
Partnerships and alliances
Access Accelerated is driving unprecedented collaboration to advance global progress on noncommunicable diseases (NCDs) for those who need it most.
African Medicines Agency Treaty Alliance
IFPMA is a founding member of the African Medicines Agency Treaty Alliance (AMATA), set up to advocate for the rapid ratification and implementation of the African Medicines Agency Treaty (AMA).
Africa Young Innovators for Health Award
The Africa Young Innovators for Health Award was created by IFPMA and Speak Up Africa to offer pioneering young health entrepreneurs across Africa financial and in-kind opportunities to bring their game-changing business ideas to life.
AMR Action Fund
The industry-led AMR Action Fund organized by IFPMA is a groundbreaking USD 1 billion initiative that aims to bring 2-4 new antibiotics to patients by 2030.
AMR Industry Alliance
The AMR Industry Alliance, chaired by IFPMA, is one of the largest private sector coalitions providing sustainable solutions to curb antimicrobial resistance (AMR).
BeCOME (Beyond COVID Monitoring Excellence) was initiated to create a sustainable forum where experts in pharmacovigilance and pharmacoepidemiology from industry, public health, regulators, and academia can collectively meet.
Business Ethics for APEC SMEs Initiative
The Business Ethics for APEC SMEs Initiative is the world's largest public-private partnership to strengthen ethical business practices in the innovative pharmaceutical sector relating to small- and medium enterprises.
Consensus Frameworks for Ethical Collaboration
Consensus Frameworks for Ethical Collaboration are multi-stakeholder, collective action initiatives that outline shared principles and a common approach to guiding ethical conduct and collaboration for actors in healthcare.
Fight the Fakes Alliance
IFPMA is a founding member of the Fight the Fakes Alliance, which raises awareness of the dangers of falsified and substandard medicines and gives a voice to people personally affected by them as well as those working to stop this crime.
Global Innovative Health Industries Alliance
The Global Innovative Health Industries Alliance is a collaborative platform for international associations representing biopharmaceuticals, biotech, diagnostics, medical devices, and diagnostic imaging industries to encourage dialogue and collaboration for innovation.
The H3D Foundation supports drug innovation and science in Africa through initiatives to strengthen capacity, collaboration, and advocacy for African researchers and research centers. IFPMA and member companies partner with H3D Foundation to promote health innovation in Africa.
HYPER is an exciting IFPMA initiative dedicated to empowering, connecting, and mobilizing young leaders and future decision-makers in the innovative pharmaceutical industry.
INTREPID Alliance exists to accelerate the development of new treatments for emerging viral pandemic agents through coordinated early science and R&D, policy and advocacy and stakeholder engagement. INTREPID Alliance members collectively bring expertise in drug discovery, antiviral R&D and medicine manufacturing.
Navigating Innovation & Research Opportunities (NIRO)
Helping actors in research and innovation identify opportunities within and beyond the European Union
The Patent Information Initiative for Medicines (Pat-INFORMED) is a unique partnership between the World Intellectual Property Organization (WIPO) and IFPMA, where patent holders provide information about patents covering approved medicines through a free, open access database.
Protecting the integrity of science and sport
IFPMA and the World Anti-Doping Agency (WADA) have a long-standing cooperation to protect clean sport.
The University of Yaoundé II-IFPMA Chair
The UYII-IFPMA Chair on “Health and Globalization: Laws, Policies and Market” is an initiative by the University of Yaoundé II, Cameroon, and IFPMA.
Women In Innovation
Launched in 2021, Women in Innovation (WIIN) is an initiative created by IFPMA to celebrate the contribution made to societies by women leaders, innovators, and creators.
Biopharmaceutical Chief Executive Officers (CEO) Roundtable
The Biopharmaceutical Chief Executive Officers (CEO) Roundtable is a global policy forum held biannually and organized by IFPMA.
Chief Ethics and Compliance Officers (CECO) Roundtable
The Chief Ethics and Compliance Officers (CECO) Roundtable is a biannual forum bringing together the most senior executive Ethics & Compliance officers of IFPMA member companies.